{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T13:08:47Z","timestamp":1779023327455,"version":"3.51.4"},"reference-count":64,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.csbj.2020.12.028","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T07:12:29Z","timestamp":1609225949000},"page":"424-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2"],"prefix":"10.34133","volume":"19","author":[{"given":"Abhinit","family":"Kumar","sequence":"first","affiliation":[{"name":"GNRPC, CSIR \u2013 Institute of Microbial Technology, Chandigarh - 160036, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Loharch","sequence":"additional","affiliation":[{"name":"GNRPC, CSIR \u2013 Institute of Microbial Technology, Chandigarh - 160036, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[{"name":"GNRPC, CSIR \u2013 Institute of Microbial Technology, Chandigarh - 160036, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh P.","family":"Ringe","sequence":"additional","affiliation":[{"name":"GNRPC, CSIR \u2013 Institute of Microbial Technology, Chandigarh - 160036, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Parkesh","sequence":"additional","affiliation":[{"name":"GNRPC, CSIR \u2013 Institute of Microbial Technology, Chandigarh - 160036, India"},{"name":"Academy of Scientific and Innovation Research (AcSIR), Ghaziabad - 201002, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2090"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211721"},{"key":"e_1_3_5_5_2","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","author":"Zhu N.","year":"2020","unstructured":"Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R. and Niu P.: A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; .","journal-title":"N Engl J Med"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.03.003"},{"key":"e_1_3_5_8_2","article-title":"Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study","author":"Elfiky A.A.","year":"2020","unstructured":"Elfiky A.A.: Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci 2020; .","journal-title":"Life Sci"},{"key":"e_1_3_5_9_2","unstructured":"https:\/\/www.fda.gov\/news-events\/pressannouncements\/coronavirus-covid-19-update-fda-issues-emergency use-authorization-potential-covid-19-treatment. Accessed on April 28 2020."},{"key":"e_1_3_5_10_2","first-page":"456","article-title":"The modern drug discovery process","author":"Noe M.C.","year":"2014","unstructured":"Noe M.C.: The modern drug discovery process. Handbook Med Chem 2014; : 456.","journal-title":"Handbook Med Chem"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci100050t"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.588508","article-title":"Current prevention of COVID-19: Natural products and herbal medicine","volume":"11","author":"Huang J.","year":"2020","unstructured":"Huang J., Tao G., Liu J., Cai J., Huang Z. and Chen J.X.: Current prevention of COVID-19: Natural products and herbal medicine. Front Pharmacol 2020; 11.","journal-title":"Front Pharmacol"},{"key":"e_1_3_5_13_2","first-page":"1","article-title":"Drug repurposing approach to fight COVID-19","author":"Singh T.U.","year":"2020","unstructured":"Singh T.U., Parida S., Lingaraju M.C., Kesavan M., Kumar D. and Singh R.K.: Drug repurposing approach to fight COVID-19. Pharmacol Rep 2020; : 1.","journal-title":"Pharmacol Rep"},{"key":"e_1_3_5_14_2","doi-asserted-by":"crossref","unstructured":"Rosa S.G.V. Santos W.C. Clinical trials on drug repositioning for COVID-19 treatment. Revista Panamericana de Salud P\u00fablica 2020 44 DOI.org\/10.26633\/RPSP.2020.40","DOI":"10.26633\/RPSP.2020.40"},{"key":"e_1_3_5_15_2","unstructured":"https:\/\/www.selleckchem.com\/screening\/fda-approved-drug-library.html Accessed on December 16 2020."},{"key":"e_1_3_5_16_2","unstructured":"Instant JChem was used for structure database management search and prediction. Instant J Chem 19.21.5 2020 ChemAxon."},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci025584y"},{"key":"e_1_3_5_18_2","unstructured":"Landrum G. Rdkit: A software suite for cheminformatics computational chemistry and predictive modeling. http:\/\/www.rdkit.org\/RDKit_Overview.pdf"},{"key":"e_1_3_5_19_2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/978-1-0716-0150-1_32","article-title":"alvaDesc: A tool to calculate and analyze molecular descriptors and fingerprints","author":"Mauri A.","year":"2020","unstructured":"Mauri A.: alvaDesc: A tool to calculate and analyze molecular descriptors and fingerprints. Ecotoxicol QSARs 2020; : 801.","journal-title":"Ecotoxicol QSARs"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci500588j"},{"key":"e_1_3_5_21_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nchembio.187","article-title":"Interactive exploration of chemical space with Scaffold Hunter","volume":"5","author":"Wetzel S.","year":"2009","unstructured":"Wetzel S., Klein K., Renner S., Rauh D., Oprea T.I., Mutzel P. and Waldmann H.: Interactive exploration of chemical space with Scaffold Hunter. Nat Chem Biol 2009; 5: 581.","journal-title":"Nat Chem Biol"},{"key":"e_1_3_5_22_2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/minf.201100078","article-title":"Rule-based classification of chemical structures by scaffold","volume":"30","author":"Schuffenhauer A.","year":"2011","unstructured":"Schuffenhauer A. and Varin T.: Rule-based classification of chemical structures by scaffold. Mol Inf 2011; 30: 646.","journal-title":"Mol Inf"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","unstructured":"Willett P. Barnard J. M. Downs G. M. Chemical similarity searching.Journal of chemical information and computer sciences 1998 38(6) 983-996","DOI":"10.1021\/ci9800211"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","unstructured":"P Mazanetz M. J Marmon R. BT Reisser C. Morao I. Drug discovery applications for KNIME: an open source data mining platform. Current topics in medicinal chemistry 2012 12(18) 1965-1979.","DOI":"10.2174\/156802612804910331"},{"key":"e_1_3_5_25_2","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1021\/acs.jcim.5b00292","article-title":"MONA 2: a light cheminformatics platform for interactive compound library processing","volume":"55","author":"Hilbig M.","year":"2015","unstructured":"Hilbig M. and Rarey M.: MONA 2: a light cheminformatics platform for interactive compound library processing. J Chem Inf Model 2015; 55: 2071.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_5_26_2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3390\/molecules21111591","article-title":"Structural analysis of sortase A inhibitors","volume":"21","author":"Nitulescu G.","year":"2016","unstructured":"Nitulescu G., Zanfirescu A., Olaru O.T., Nicorescu I.M., Nitulescu G.M. and Margina D.: Structural analysis of sortase A inhibitors. Molecules 2016; 21: 1591.","journal-title":"Molecules"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm9602928"},{"key":"e_1_3_5_28_2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1021\/ci7004093","article-title":"Structure-activity landscape index: identifying and quantifying activity cliffs","volume":"48","author":"Guha R.","year":"2008","unstructured":"Guha R. and Van Drie J.H.: Structure-activity landscape index: identifying and quantifying activity cliffs. J Chem Inf Model 2008; 48: 646.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_5_29_2","doi-asserted-by":"crossref","unstructured":"Bastian M. Heymann S. Jacomy M. March. Gephi: an open-source software for exploring and manipulating networks. In Third international AAAI conference on weblogs and social media 2009.","DOI":"10.1609\/icwsm.v3i1.13937"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr320"},{"key":"e_1_3_5_31_2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1021\/mp060034z","article-title":"Discovering H-bonding rules in crystals with inductive logic programming","volume":"3","author":"Ando H.Y.","year":"2006","unstructured":"Ando H.Y., Dehaspe L., Luyten W., Van Craenenbroeck E., Vandecasteele H. and Van Meervelt L.: Discovering H-bonding rules in crystals with inductive logic programming. Mol Pharm 2006; 3: 665.","journal-title":"Mol Pharm"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2019-0096"},{"key":"e_1_3_5_33_2","doi-asserted-by":"crossref","unstructured":"Lorenz M.O. Methods of measuring the concentration of wealth.Publications of the American statistical association 1905 9(70) pp.209-219","DOI":"10.1080\/15225437.1905.10503443"},{"key":"e_1_3_5_34_2","article-title":"Variabilit\u00e0 e mutabilit\u00e0","author":"Gini C.","year":"1912","unstructured":"Gini C.: Variabilit\u00e0 e mutabilit\u00e0. Vamu 1912; .","journal-title":"Vamu"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature15392"},{"key":"e_1_3_5_36_2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jksues.2017.12.001","article-title":"A Gini coefficient based evaluation on the reliability of travel time forecasting","volume":"31","author":"Lee S.B.","year":"2019","unstructured":"Lee S.B., Lee S.M. and Lee K.Y.: A Gini coefficient based evaluation on the reliability of travel time forecasting. J King Saud Univ-Eng Sci 2019; 31: 314.","journal-title":"J King Saud Univ-Eng Sci"},{"key":"e_1_3_5_37_2","first-page":"1","article-title":"A novel application of Gini coefficient for the quantitative measurement of bacterial aggregation","volume":"9","author":"Cai Y.M.","year":"2019","unstructured":"Cai Y.M., Chatelet D.S., Howlin R.P., Wang Z.Z. and Webb J.S.: A novel application of Gini coefficient for the quantitative measurement of bacterial aggregation. Sci Rep 2019; 9: 1.","journal-title":"Sci Rep"},{"key":"e_1_3_5_38_2","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jcc.24423","article-title":"Using the Gini coefficient to measure the chemical diversity of small-molecule libraries","volume":"37","author":"Weidlich I.E.","year":"2016","unstructured":"Weidlich I.E. and Filippov I.V.: Using the Gini coefficient to measure the chemical diversity of small-molecule libraries. J Comput Chem 2016; 37: 2091.","journal-title":"J Comput Chem"},{"key":"e_1_3_5_39_2","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1021\/ci2001428","article-title":"Scaffold diversity of exemplified medicinal chemistry space","volume":"51","author":"Langdon S.R.","year":"2011","unstructured":"Langdon S.R., Brown N. and Blagg J.: Scaffold diversity of exemplified medicinal chemistry space. J Chem Inf Model 2011; 51: 2174.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1021\/jo8001276"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.06.081"},{"key":"e_1_3_5_42_2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.18433\/J3BS4H","article-title":"To be drug or prodrug: structure-property exploratory approach regarding oral bioavailability","volume":"17","author":"Dami\u00e3o M.C.F.C.B.","year":"2014","unstructured":"Dami\u00e3o M.C.F.C.B., Pasqualoto K.F.M., Polli M.C. and PariseFilho R.: To be drug or prodrug: structure-property exploratory approach regarding oral bioavailability. J Pharm Pharm Sci 2014; 17: 532.","journal-title":"J Pharm Pharm Sci"},{"key":"e_1_3_5_43_2","doi-asserted-by":"crossref","unstructured":"42. Loharch S. Karmahapatra V. Gupta P. Madathil R. and Parkesh R. Integrated cheminformatics approaches toward epigenetic drug discovery. In Structural Bioinformatics: Applications in Preclinical Drug Discovery Process 2019 247-269. Springer Nature.","DOI":"10.1007\/978-3-030-05282-9_8"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm020017n"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C300328200"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.18.9977-9986.2004"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb3405"},{"key":"e_1_3_5_48_2","first-page":"1","article-title":"Structure of M pro from SARS-CoV-2 and discovery of its inhibitors","author":"Jin Z.","year":"2020","unstructured":"Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C. and Duan Y.: Structure of M pro from SARS-CoV-2 and discovery of its inhibitors. Nature 2020; : 1.","journal-title":"Nature"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.24.15189-15198.2005"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8719(00)00107-6"},{"key":"e_1_3_5_51_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13321-017-0235-x","article-title":"Molecular de-novo design through deep reinforcement learning","volume":"9","author":"Olivecrona M.","year":"2017","unstructured":"Olivecrona M., Blaschke T., Engkvist O. and Chen H.: Molecular de-novo design through deep reinforcement learning. J Cheminf 2017; 9: 48.","journal-title":"J Cheminf"},{"key":"e_1_3_5_52_2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"(2010) Extended-connectivity fingerprints","volume":"50","author":"Rogers D.","year":"2010","unstructured":"Rogers D. and Hahn M.: (2010) Extended-connectivity fingerprints. J Chem Inf Model 2010; 50: 742.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_5_53_2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1609\/icwsm.v3i1.13937","article-title":"Gephi: an open source software for exploring and manipulating networks","volume":"2009","author":"Bastian M.","year":"2009","unstructured":"Bastian M., Heymann S. and Jacomy M.: Gephi: an open source software for exploring and manipulating networks. Icwsm 2009; 2009: 361.","journal-title":"Icwsm"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.03.007"},{"key":"e_1_3_5_55_2","doi-asserted-by":"crossref","unstructured":"Chopra G. Samudrala R. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform. Curr Pharm Des. 2016 22 3109-23","DOI":"10.2174\/1381612822666160325121943"},{"key":"e_1_3_5_56_2","doi-asserted-by":"crossref","unstructured":"De Wilde A.H. Jochmans D. Posthuma C.C. Zevenhoven-Dobbe J.C. Van Nieuwkoop S. Bestebroer T.M. Van Den Hoogen B.G. Neyts J. Snijder E.J. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.Antimicrobial agents and chemotherapy 2014 58(8) 4875-4884.","DOI":"10.1128\/AAC.03011-14"},{"key":"e_1_3_5_57_2","first-page":"13","article-title":"Raltegravir in HIV-1 infection: safety and efficacy in treatment-naive patients","volume":"2012","author":"Pandey K.K.","year":"2011","unstructured":"Pandey K.K.: Raltegravir in HIV-1 infection: safety and efficacy in treatment-naive patients. Clin Med Rev Therapeut 2011; 2012: 13.","journal-title":"Clin Med Rev Therapeut"},{"key":"e_1_3_5_58_2","first-page":"1","article-title":"Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2\u2032-O-ribose methyltransferase","author":"Khan R.J.","year":"2020","unstructured":"Khan R.J., Jha R.K., Amera G.M., Jain M., Singh E., Pathak A., Singh R.P., Muthukumaran J. and Singh A.K.: Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2\u2032-O-ribose methyltransferase. J Biomol Struct Dyn 2020; : 1.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_5_59_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110111","article-title":"Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin","volume":"143","author":"Mozafari N.","year":"2020","unstructured":"Mozafari N., Azadi S., Mehdi-Alamdarlou S., Ashrafi H. and Azadi A.: Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin. Med Hypotheses 2020; 143.","journal-title":"Med Hypotheses"},{"key":"e_1_3_5_60_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/17460441.2019.1581170","article-title":"DataWarrior: An evaluation of the open-source drug discovery tool","volume":"14","author":"L\u00f3pez-L\u00f3pez E.","year":"2019","unstructured":"L\u00f3pez-L\u00f3pez E., Naveja J.J. and Medina-Franco J.L.: DataWarrior: An evaluation of the open-source drug discovery tool. Expert Opin Drug Discov 2019; 14: 335.","journal-title":"Expert Opin Drug Discov"},{"key":"e_1_3_5_61_2","first-page":"1","article-title":"Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach","author":"Kanhed A.M.","year":"2020","unstructured":"Kanhed A.M., Patel D.V., Teli D.M., Patel N.R., Chhabria M.T. and Yadav M.R.: Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach. Mol Diversity 2020; : 1.","journal-title":"Mol Diversity"},{"key":"e_1_3_5_62_2","doi-asserted-by":"crossref","first-page":"0751","DOI":"10.1126\/sciadv.abe0751","article-title":"Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L","volume":"6","author":"Sacco M.D.","year":"2020","unstructured":"Sacco M.D., Ma C., Lagarias P., Gao A., Townsend J.A., Meng X., Dube P., Zhang X., Hu Y., Kitamura N. and Hurst B.: Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L. Sci Adv 2020; 6: 0751.","journal-title":"Sci Adv"},{"key":"e_1_3_5_63_2","first-page":"51","article-title":"Recent Review on Indole: A Privileged Structure Scaffold","volume":"7","author":"Naim M.J.","year":"2016","unstructured":"Naim M.J., Alam O., Alam J., Bano F., Alam P. and Shrivastava N.: Recent Review on Indole: A Privileged Structure Scaffold. Int J Pharm Sci Res 2016; 7: 51.","journal-title":"Int J Pharm Sci Res"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1586\/ecp.12.74"},{"key":"e_1_3_5_65_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104351","article-title":"Emergence of genomic diversity and recurrent mutations in SARS-CoV-2","author":"van Dorp L.","year":"2020","unstructured":"van Dorp L., Acman M., Richard D., Shaw L.P., Ford C.E., Ormond L., Owen C.J., Pang J., Tan C.C., Boshier F.A. and Ortiz A.T.: Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol 2020; .","journal-title":"Infect Genet Evol"}],"updated-by":[{"DOI":"10.1016\/j.csbj.2023.09.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000}}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037020305535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037020305535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2020.12.028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:42:39Z","timestamp":1779021759000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2020.12.028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":64,"alternative-id":["10.1016\/j.csbj.2020.12.028"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2020.12.028","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2020.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}